India Coronavirus Dispatch: Experts remain unconvinced about Covaxin nod

Online tool spots patients at risk of deterioration, vaccines to be guarded like poll ballots, post-Covid effects on six key organs-news relevant to India's fight against Covid-19

Top virologist says will not take Covaxin until efficacy data is out

India's national drug regulator has approved the Covid-19 vaccines of both Serum Institute of India (SII) and Bharat Biotech for restricted use in the country. However, experts have severely criticised the regulator for clearing Bharat Biotech's Covaxin even though the efficacy data is available yet. Noted Indian virologist Gagandeep Kang shares her views in a report in The Hindu.

Kang said Bharat Biotech has data from animal challenge studies that are "supportive" of efficacy, but that doesn't automatically imply human efficacy. From humans, the drugmaker must be following up their